Sirius NeoSight est une société innovante de rupture technologique qui a pour ambition de devenir un acteur incontournable dans la détection des néo-cancers infracliniques, des rechutes et le suivi thérapeutique des patients proposant ainsi un nouveau regard aux médecins sur l’efficacité thérapeutique mise en oeuvre.
Sirius NeoSight exploite une technologie de rupture issue brevetée issue d’un consortium de laboratoires académiques experts du domaine.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Avenue Rockefeller, Lyon,auvergne-Rhône-Alpes,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://sirius-neosight.com/
- HQ
- Lyon, Auvergne-Rhône-Alpes
Sirius Neosight Questions
Sirius Neosight's website is https://sirius-neosight.com/
Sirius Neosight's LinkedIn profile is https://fr.linkedin.com/company/sirius-neosight
Sirius Neosight has
8 employees.
View email and phone details for 8
employees at Sirius Neosight.
Sirius Neosight's industry is
Biotechnology Research
Sirius Neosight's top competitors are
Fabera,
Reev,
Manitty,
Osta Therapeutics,
Superbranche,
Circle Safe,
Netri,
Lys Therapeutics,
Ervimmune,
Thepackengers.
Sirius Neosight's categories are Biotechnology Research
Sirius Neosight's founding year is 2023
